NEW DELHI: India announced on Tuesday (Apr 7) a partial lifting of a fresh export ban on a malaria drug seen as a potential COVID-19 treatment, after US President Donald Trump hinted at "retaliation".
Citing domestic needs, India banned on Saturday exports of hydroxychloroquine which has shown early promise against COVID-19 in small-scale studies in France and China.
Advertisement Advertisement India is the world's largest producer and exporter of the drug, according to media reports. Global